nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP2C8—Etoposide—muscle cancer	0.0732	0.471	CbGbCtD
Metronidazole—CYP3A4—Vincristine—muscle cancer	0.0324	0.208	CbGbCtD
Metronidazole—CYP3A4—Etoposide—muscle cancer	0.0297	0.191	CbGbCtD
Metronidazole—CYP3A4—Doxorubicin—muscle cancer	0.0202	0.13	CbGbCtD
Metronidazole—Anorexia—Vincristine—muscle cancer	0.00165	0.00196	CcSEcCtD
Metronidazole—Hepatic failure—Doxorubicin—muscle cancer	0.00165	0.00195	CcSEcCtD
Metronidazole—Irritability—Methotrexate—muscle cancer	0.00163	0.00193	CcSEcCtD
Metronidazole—Ataxia—Methotrexate—muscle cancer	0.00161	0.00191	CcSEcCtD
Metronidazole—Feeling abnormal—Dactinomycin—muscle cancer	0.0016	0.00189	CcSEcCtD
Metronidazole—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00159	0.00188	CcSEcCtD
Metronidazole—Liver function test abnormal—Methotrexate—muscle cancer	0.00158	0.00187	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00158	0.00187	CcSEcCtD
Metronidazole—Insomnia—Vincristine—muscle cancer	0.00157	0.00186	CcSEcCtD
Metronidazole—Paraesthesia—Vincristine—muscle cancer	0.00156	0.00184	CcSEcCtD
Metronidazole—Malaise—Etoposide—muscle cancer	0.00155	0.00184	CcSEcCtD
Metronidazole—Dermatitis bullous—Doxorubicin—muscle cancer	0.00155	0.00184	CcSEcCtD
Metronidazole—Breast disorder—Methotrexate—muscle cancer	0.00155	0.00183	CcSEcCtD
Metronidazole—Vertigo—Etoposide—muscle cancer	0.00155	0.00183	CcSEcCtD
Metronidazole—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00154	0.00182	CcSEcCtD
Metronidazole—Leukopenia—Etoposide—muscle cancer	0.00154	0.00182	CcSEcCtD
Metronidazole—Body temperature increased—Dactinomycin—muscle cancer	0.00153	0.00182	CcSEcCtD
Metronidazole—Abdominal pain—Dactinomycin—muscle cancer	0.00153	0.00182	CcSEcCtD
Metronidazole—Loss of consciousness—Etoposide—muscle cancer	0.00151	0.00179	CcSEcCtD
Metronidazole—Decreased appetite—Vincristine—muscle cancer	0.00151	0.00178	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Vincristine—muscle cancer	0.0015	0.00177	CcSEcCtD
Metronidazole—Fatigue—Vincristine—muscle cancer	0.00149	0.00177	CcSEcCtD
Metronidazole—Convulsion—Etoposide—muscle cancer	0.00149	0.00177	CcSEcCtD
Metronidazole—Hypertension—Etoposide—muscle cancer	0.00149	0.00176	CcSEcCtD
Metronidazole—Pain—Vincristine—muscle cancer	0.00148	0.00176	CcSEcCtD
Metronidazole—Constipation—Vincristine—muscle cancer	0.00148	0.00176	CcSEcCtD
Metronidazole—Osteoarthritis—Doxorubicin—muscle cancer	0.00148	0.00175	CcSEcCtD
Metronidazole—Diplopia—Doxorubicin—muscle cancer	0.00148	0.00175	CcSEcCtD
Metronidazole—Asthma—Methotrexate—muscle cancer	0.00148	0.00175	CcSEcCtD
Metronidazole—Chest pain—Etoposide—muscle cancer	0.00146	0.00173	CcSEcCtD
Metronidazole—Eosinophilia—Methotrexate—muscle cancer	0.00146	0.00173	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00145	0.00172	CcSEcCtD
Metronidazole—Pancreatitis—Methotrexate—muscle cancer	0.00145	0.00172	CcSEcCtD
Metronidazole—Hypersensitivity—Dactinomycin—muscle cancer	0.00143	0.00169	CcSEcCtD
Metronidazole—Abdominal discomfort—Methotrexate—muscle cancer	0.00142	0.00168	CcSEcCtD
Metronidazole—Gastrointestinal pain—Vincristine—muscle cancer	0.00142	0.00168	CcSEcCtD
Metronidazole—Confusional state—Etoposide—muscle cancer	0.00142	0.00168	CcSEcCtD
Metronidazole—Pancytopenia—Methotrexate—muscle cancer	0.0014	0.00166	CcSEcCtD
Metronidazole—Anaphylactic shock—Etoposide—muscle cancer	0.0014	0.00166	CcSEcCtD
Metronidazole—Infection—Etoposide—muscle cancer	0.0014	0.00165	CcSEcCtD
Metronidazole—Ataxia—Doxorubicin—muscle cancer	0.00139	0.00165	CcSEcCtD
Metronidazole—Asthenia—Dactinomycin—muscle cancer	0.00139	0.00165	CcSEcCtD
Metronidazole—Neutropenia—Methotrexate—muscle cancer	0.00138	0.00164	CcSEcCtD
Metronidazole—Dysuria—Methotrexate—muscle cancer	0.00138	0.00164	CcSEcCtD
Metronidazole—Thrombocytopenia—Etoposide—muscle cancer	0.00138	0.00163	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00137	0.00163	CcSEcCtD
Metronidazole—Abdominal pain—Vincristine—muscle cancer	0.00137	0.00162	CcSEcCtD
Metronidazole—Body temperature increased—Vincristine—muscle cancer	0.00137	0.00162	CcSEcCtD
Metronidazole—Liver function test abnormal—Doxorubicin—muscle cancer	0.00137	0.00162	CcSEcCtD
Metronidazole—Skin disorder—Etoposide—muscle cancer	0.00136	0.00162	CcSEcCtD
Metronidazole—Dry skin—Doxorubicin—muscle cancer	0.00136	0.00161	CcSEcCtD
Metronidazole—Hyperhidrosis—Etoposide—muscle cancer	0.00136	0.00161	CcSEcCtD
Metronidazole—Abdominal pain upper—Doxorubicin—muscle cancer	0.00135	0.0016	CcSEcCtD
Metronidazole—Photosensitivity reaction—Methotrexate—muscle cancer	0.00135	0.0016	CcSEcCtD
Metronidazole—Breast disorder—Doxorubicin—muscle cancer	0.00134	0.00159	CcSEcCtD
Metronidazole—Anorexia—Etoposide—muscle cancer	0.00134	0.00159	CcSEcCtD
Metronidazole—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00133	0.00158	CcSEcCtD
Metronidazole—Diarrhoea—Dactinomycin—muscle cancer	0.00133	0.00157	CcSEcCtD
Metronidazole—Nasopharyngitis—Doxorubicin—muscle cancer	0.00133	0.00157	CcSEcCtD
Metronidazole—Drowsiness—Methotrexate—muscle cancer	0.00132	0.00156	CcSEcCtD
Metronidazole—Infestation NOS—Methotrexate—muscle cancer	0.00132	0.00156	CcSEcCtD
Metronidazole—Infestation—Methotrexate—muscle cancer	0.00132	0.00156	CcSEcCtD
Metronidazole—Depression—Methotrexate—muscle cancer	0.00132	0.00156	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00131	0.00155	CcSEcCtD
Metronidazole—Abdominal distension—Doxorubicin—muscle cancer	0.00129	0.00153	CcSEcCtD
Metronidazole—Stomatitis—Methotrexate—muscle cancer	0.00129	0.00152	CcSEcCtD
Metronidazole—Conjunctivitis—Methotrexate—muscle cancer	0.00128	0.00152	CcSEcCtD
Metronidazole—Influenza—Doxorubicin—muscle cancer	0.00128	0.00152	CcSEcCtD
Metronidazole—Asthma—Doxorubicin—muscle cancer	0.00128	0.00152	CcSEcCtD
Metronidazole—Hypersensitivity—Vincristine—muscle cancer	0.00128	0.00151	CcSEcCtD
Metronidazole—Eosinophilia—Doxorubicin—muscle cancer	0.00127	0.0015	CcSEcCtD
Metronidazole—Sweating—Methotrexate—muscle cancer	0.00126	0.0015	CcSEcCtD
Metronidazole—Paraesthesia—Etoposide—muscle cancer	0.00126	0.00149	CcSEcCtD
Metronidazole—Pancreatitis—Doxorubicin—muscle cancer	0.00126	0.00149	CcSEcCtD
Metronidazole—Somnolence—Etoposide—muscle cancer	0.00125	0.00148	CcSEcCtD
Metronidazole—Hepatobiliary disease—Methotrexate—muscle cancer	0.00125	0.00148	CcSEcCtD
Metronidazole—Asthenia—Vincristine—muscle cancer	0.00124	0.00147	CcSEcCtD
Metronidazole—Vomiting—Dactinomycin—muscle cancer	0.00123	0.00146	CcSEcCtD
Metronidazole—Bronchitis—Doxorubicin—muscle cancer	0.00123	0.00146	CcSEcCtD
Metronidazole—Agranulocytosis—Methotrexate—muscle cancer	0.00123	0.00146	CcSEcCtD
Metronidazole—Rash—Dactinomycin—muscle cancer	0.00122	0.00145	CcSEcCtD
Metronidazole—Decreased appetite—Etoposide—muscle cancer	0.00122	0.00145	CcSEcCtD
Metronidazole—Pancytopenia—Doxorubicin—muscle cancer	0.00122	0.00144	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Etoposide—muscle cancer	0.00121	0.00144	CcSEcCtD
Metronidazole—Fatigue—Etoposide—muscle cancer	0.00121	0.00143	CcSEcCtD
Metronidazole—Constipation—Etoposide—muscle cancer	0.0012	0.00142	CcSEcCtD
Metronidazole—Pain—Etoposide—muscle cancer	0.0012	0.00142	CcSEcCtD
Metronidazole—Dysuria—Doxorubicin—muscle cancer	0.0012	0.00142	CcSEcCtD
Metronidazole—Neutropenia—Doxorubicin—muscle cancer	0.0012	0.00142	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00119	0.00141	CcSEcCtD
Metronidazole—Diarrhoea—Vincristine—muscle cancer	0.00119	0.0014	CcSEcCtD
Metronidazole—Hepatitis—Methotrexate—muscle cancer	0.00118	0.0014	CcSEcCtD
Metronidazole—Pollakiuria—Doxorubicin—muscle cancer	0.00118	0.0014	CcSEcCtD
Metronidazole—Pharyngitis—Methotrexate—muscle cancer	0.00118	0.00139	CcSEcCtD
Metronidazole—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00117	0.00138	CcSEcCtD
Metronidazole—Feeling abnormal—Etoposide—muscle cancer	0.00116	0.00137	CcSEcCtD
Metronidazole—Nausea—Dactinomycin—muscle cancer	0.00115	0.00136	CcSEcCtD
Metronidazole—Gastrointestinal pain—Etoposide—muscle cancer	0.00115	0.00136	CcSEcCtD
Metronidazole—Dizziness—Vincristine—muscle cancer	0.00115	0.00136	CcSEcCtD
Metronidazole—Drowsiness—Doxorubicin—muscle cancer	0.00114	0.00135	CcSEcCtD
Metronidazole—Infestation—Doxorubicin—muscle cancer	0.00114	0.00135	CcSEcCtD
Metronidazole—Infestation NOS—Doxorubicin—muscle cancer	0.00114	0.00135	CcSEcCtD
Metronidazole—Visual impairment—Methotrexate—muscle cancer	0.00114	0.00135	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00113	0.00134	CcSEcCtD
Metronidazole—Erythema multiforme—Methotrexate—muscle cancer	0.00112	0.00133	CcSEcCtD
Metronidazole—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00112	0.00133	CcSEcCtD
Metronidazole—Urticaria—Etoposide—muscle cancer	0.00112	0.00132	CcSEcCtD
Metronidazole—Stomatitis—Doxorubicin—muscle cancer	0.00111	0.00132	CcSEcCtD
Metronidazole—Jaundice—Doxorubicin—muscle cancer	0.00111	0.00132	CcSEcCtD
Metronidazole—Abdominal pain—Etoposide—muscle cancer	0.00111	0.00131	CcSEcCtD
Metronidazole—Body temperature increased—Etoposide—muscle cancer	0.00111	0.00131	CcSEcCtD
Metronidazole—Urinary tract infection—Doxorubicin—muscle cancer	0.00111	0.00131	CcSEcCtD
Metronidazole—Conjunctivitis—Doxorubicin—muscle cancer	0.00111	0.00131	CcSEcCtD
Metronidazole—Eye disorder—Methotrexate—muscle cancer	0.00111	0.00131	CcSEcCtD
Metronidazole—Tinnitus—Methotrexate—muscle cancer	0.0011	0.00131	CcSEcCtD
Metronidazole—Vomiting—Vincristine—muscle cancer	0.0011	0.00131	CcSEcCtD
Metronidazole—Cardiac disorder—Methotrexate—muscle cancer	0.0011	0.0013	CcSEcCtD
Metronidazole—Sweating—Doxorubicin—muscle cancer	0.00109	0.0013	CcSEcCtD
Metronidazole—Rash—Vincristine—muscle cancer	0.00109	0.00129	CcSEcCtD
Metronidazole—Dermatitis—Vincristine—muscle cancer	0.00109	0.00129	CcSEcCtD
Metronidazole—Headache—Vincristine—muscle cancer	0.00109	0.00129	CcSEcCtD
Metronidazole—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00108	0.00128	CcSEcCtD
Metronidazole—Angiopathy—Methotrexate—muscle cancer	0.00107	0.00127	CcSEcCtD
Metronidazole—Sinusitis—Doxorubicin—muscle cancer	0.00107	0.00127	CcSEcCtD
Metronidazole—Immune system disorder—Methotrexate—muscle cancer	0.00107	0.00127	CcSEcCtD
Metronidazole—Mediastinal disorder—Methotrexate—muscle cancer	0.00107	0.00126	CcSEcCtD
Metronidazole—Agranulocytosis—Doxorubicin—muscle cancer	0.00107	0.00126	CcSEcCtD
Metronidazole—Mental disorder—Methotrexate—muscle cancer	0.00104	0.00123	CcSEcCtD
Metronidazole—Hypersensitivity—Etoposide—muscle cancer	0.00103	0.00123	CcSEcCtD
Metronidazole—Erythema—Methotrexate—muscle cancer	0.00103	0.00122	CcSEcCtD
Metronidazole—Nausea—Vincristine—muscle cancer	0.00103	0.00122	CcSEcCtD
Metronidazole—Rhinitis—Doxorubicin—muscle cancer	0.00103	0.00122	CcSEcCtD
Metronidazole—Hepatitis—Doxorubicin—muscle cancer	0.00103	0.00121	CcSEcCtD
Metronidazole—Hypoaesthesia—Doxorubicin—muscle cancer	0.00102	0.00121	CcSEcCtD
Metronidazole—Pharyngitis—Doxorubicin—muscle cancer	0.00102	0.0012	CcSEcCtD
Metronidazole—Dysgeusia—Methotrexate—muscle cancer	0.00101	0.0012	CcSEcCtD
Metronidazole—Asthenia—Etoposide—muscle cancer	0.00101	0.00119	CcSEcCtD
Metronidazole—Connective tissue disorder—Doxorubicin—muscle cancer	0.00101	0.00119	CcSEcCtD
Metronidazole—Back pain—Methotrexate—muscle cancer	0.000997	0.00118	CcSEcCtD
Metronidazole—Pruritus—Etoposide—muscle cancer	0.000994	0.00118	CcSEcCtD
Metronidazole—Visual impairment—Doxorubicin—muscle cancer	0.000988	0.00117	CcSEcCtD
Metronidazole—Vision blurred—Methotrexate—muscle cancer	0.000971	0.00115	CcSEcCtD
Metronidazole—Erythema multiforme—Doxorubicin—muscle cancer	0.000969	0.00115	CcSEcCtD
Metronidazole—Diarrhoea—Etoposide—muscle cancer	0.000961	0.00114	CcSEcCtD
Metronidazole—Eye disorder—Doxorubicin—muscle cancer	0.000958	0.00113	CcSEcCtD
Metronidazole—Tinnitus—Doxorubicin—muscle cancer	0.000956	0.00113	CcSEcCtD
Metronidazole—Flushing—Doxorubicin—muscle cancer	0.000951	0.00113	CcSEcCtD
Metronidazole—Cardiac disorder—Doxorubicin—muscle cancer	0.000951	0.00113	CcSEcCtD
Metronidazole—Angiopathy—Doxorubicin—muscle cancer	0.00093	0.0011	CcSEcCtD
Metronidazole—Malaise—Methotrexate—muscle cancer	0.000929	0.0011	CcSEcCtD
Metronidazole—Dizziness—Etoposide—muscle cancer	0.000929	0.0011	CcSEcCtD
Metronidazole—Immune system disorder—Doxorubicin—muscle cancer	0.000926	0.0011	CcSEcCtD
Metronidazole—Vertigo—Methotrexate—muscle cancer	0.000926	0.0011	CcSEcCtD
Metronidazole—Mediastinal disorder—Doxorubicin—muscle cancer	0.000924	0.00109	CcSEcCtD
Metronidazole—Leukopenia—Methotrexate—muscle cancer	0.000923	0.00109	CcSEcCtD
Metronidazole—Mental disorder—Doxorubicin—muscle cancer	0.000898	0.00106	CcSEcCtD
Metronidazole—Convulsion—Methotrexate—muscle cancer	0.000893	0.00106	CcSEcCtD
Metronidazole—Vomiting—Etoposide—muscle cancer	0.000893	0.00106	CcSEcCtD
Metronidazole—Erythema—Doxorubicin—muscle cancer	0.000892	0.00106	CcSEcCtD
Metronidazole—Rash—Etoposide—muscle cancer	0.000885	0.00105	CcSEcCtD
Metronidazole—Dermatitis—Etoposide—muscle cancer	0.000885	0.00105	CcSEcCtD
Metronidazole—Headache—Etoposide—muscle cancer	0.00088	0.00104	CcSEcCtD
Metronidazole—Flatulence—Doxorubicin—muscle cancer	0.000879	0.00104	CcSEcCtD
Metronidazole—Chest pain—Methotrexate—muscle cancer	0.000877	0.00104	CcSEcCtD
Metronidazole—Arthralgia—Methotrexate—muscle cancer	0.000877	0.00104	CcSEcCtD
Metronidazole—Dysgeusia—Doxorubicin—muscle cancer	0.000874	0.00103	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000871	0.00103	CcSEcCtD
Metronidazole—Back pain—Doxorubicin—muscle cancer	0.000863	0.00102	CcSEcCtD
Metronidazole—Muscle spasms—Doxorubicin—muscle cancer	0.000858	0.00102	CcSEcCtD
Metronidazole—Confusional state—Methotrexate—muscle cancer	0.000848	0.001	CcSEcCtD
Metronidazole—Anaphylactic shock—Methotrexate—muscle cancer	0.000841	0.000996	CcSEcCtD
Metronidazole—Vision blurred—Doxorubicin—muscle cancer	0.000841	0.000996	CcSEcCtD
Metronidazole—Infection—Methotrexate—muscle cancer	0.000836	0.00099	CcSEcCtD
Metronidazole—Nausea—Etoposide—muscle cancer	0.000834	0.000988	CcSEcCtD
Metronidazole—Nervous system disorder—Methotrexate—muscle cancer	0.000825	0.000977	CcSEcCtD
Metronidazole—Thrombocytopenia—Methotrexate—muscle cancer	0.000824	0.000975	CcSEcCtD
Metronidazole—Skin disorder—Methotrexate—muscle cancer	0.000817	0.000967	CcSEcCtD
Metronidazole—Hyperhidrosis—Methotrexate—muscle cancer	0.000813	0.000963	CcSEcCtD
Metronidazole—Malaise—Doxorubicin—muscle cancer	0.000805	0.000953	CcSEcCtD
Metronidazole—Vertigo—Doxorubicin—muscle cancer	0.000802	0.000949	CcSEcCtD
Metronidazole—Anorexia—Methotrexate—muscle cancer	0.000802	0.000949	CcSEcCtD
Metronidazole—Syncope—Doxorubicin—muscle cancer	0.0008	0.000948	CcSEcCtD
Metronidazole—Leukopenia—Doxorubicin—muscle cancer	0.000799	0.000946	CcSEcCtD
Metronidazole—Palpitations—Doxorubicin—muscle cancer	0.000789	0.000934	CcSEcCtD
Metronidazole—Loss of consciousness—Doxorubicin—muscle cancer	0.000784	0.000929	CcSEcCtD
Metronidazole—Convulsion—Doxorubicin—muscle cancer	0.000773	0.000916	CcSEcCtD
Metronidazole—Hypertension—Doxorubicin—muscle cancer	0.000771	0.000912	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000766	0.000907	CcSEcCtD
Metronidazole—Insomnia—Methotrexate—muscle cancer	0.000761	0.000901	CcSEcCtD
Metronidazole—Arthralgia—Doxorubicin—muscle cancer	0.00076	0.0009	CcSEcCtD
Metronidazole—Chest pain—Doxorubicin—muscle cancer	0.00076	0.0009	CcSEcCtD
Metronidazole—Paraesthesia—Methotrexate—muscle cancer	0.000755	0.000894	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000755	0.000893	CcSEcCtD
Metronidazole—Somnolence—Methotrexate—muscle cancer	0.000748	0.000885	CcSEcCtD
Metronidazole—Dry mouth—Doxorubicin—muscle cancer	0.000743	0.00088	CcSEcCtD
Metronidazole—Dyspepsia—Methotrexate—muscle cancer	0.00074	0.000877	CcSEcCtD
Metronidazole—Confusional state—Doxorubicin—muscle cancer	0.000734	0.00087	CcSEcCtD
Metronidazole—Decreased appetite—Methotrexate—muscle cancer	0.000731	0.000866	CcSEcCtD
Metronidazole—Anaphylactic shock—Doxorubicin—muscle cancer	0.000728	0.000862	CcSEcCtD
Metronidazole—Oedema—Doxorubicin—muscle cancer	0.000728	0.000862	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000726	0.00086	CcSEcCtD
Metronidazole—Fatigue—Methotrexate—muscle cancer	0.000725	0.000859	CcSEcCtD
Metronidazole—Infection—Doxorubicin—muscle cancer	0.000724	0.000857	CcSEcCtD
Metronidazole—Pain—Methotrexate—muscle cancer	0.000719	0.000852	CcSEcCtD
Metronidazole—Shock—Doxorubicin—muscle cancer	0.000717	0.000849	CcSEcCtD
Metronidazole—Nervous system disorder—Doxorubicin—muscle cancer	0.000714	0.000846	CcSEcCtD
Metronidazole—Thrombocytopenia—Doxorubicin—muscle cancer	0.000713	0.000844	CcSEcCtD
Metronidazole—Skin disorder—Doxorubicin—muscle cancer	0.000708	0.000838	CcSEcCtD
Metronidazole—Hyperhidrosis—Doxorubicin—muscle cancer	0.000704	0.000834	CcSEcCtD
Metronidazole—Anorexia—Doxorubicin—muscle cancer	0.000694	0.000822	CcSEcCtD
Metronidazole—Feeling abnormal—Methotrexate—muscle cancer	0.000693	0.000821	CcSEcCtD
Metronidazole—Gastrointestinal pain—Methotrexate—muscle cancer	0.000688	0.000814	CcSEcCtD
Metronidazole—Urticaria—Methotrexate—muscle cancer	0.000668	0.000791	CcSEcCtD
Metronidazole—Abdominal pain—Methotrexate—muscle cancer	0.000665	0.000787	CcSEcCtD
Metronidazole—Body temperature increased—Methotrexate—muscle cancer	0.000665	0.000787	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000664	0.000786	CcSEcCtD
Metronidazole—Insomnia—Doxorubicin—muscle cancer	0.000659	0.00078	CcSEcCtD
Metronidazole—Paraesthesia—Doxorubicin—muscle cancer	0.000654	0.000774	CcSEcCtD
Metronidazole—Somnolence—Doxorubicin—muscle cancer	0.000648	0.000767	CcSEcCtD
Metronidazole—Dyspepsia—Doxorubicin—muscle cancer	0.000641	0.000759	CcSEcCtD
Metronidazole—Decreased appetite—Doxorubicin—muscle cancer	0.000633	0.00075	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000629	0.000745	CcSEcCtD
Metronidazole—Fatigue—Doxorubicin—muscle cancer	0.000628	0.000744	CcSEcCtD
Metronidazole—Constipation—Doxorubicin—muscle cancer	0.000623	0.000738	CcSEcCtD
Metronidazole—Pain—Doxorubicin—muscle cancer	0.000623	0.000738	CcSEcCtD
Metronidazole—Hypersensitivity—Methotrexate—muscle cancer	0.00062	0.000734	CcSEcCtD
Metronidazole—Asthenia—Methotrexate—muscle cancer	0.000604	0.000715	CcSEcCtD
Metronidazole—Feeling abnormal—Doxorubicin—muscle cancer	0.0006	0.000711	CcSEcCtD
Metronidazole—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000596	0.000705	CcSEcCtD
Metronidazole—Pruritus—Methotrexate—muscle cancer	0.000595	0.000705	CcSEcCtD
Metronidazole—Urticaria—Doxorubicin—muscle cancer	0.000579	0.000685	CcSEcCtD
Metronidazole—Abdominal pain—Doxorubicin—muscle cancer	0.000576	0.000682	CcSEcCtD
Metronidazole—Body temperature increased—Doxorubicin—muscle cancer	0.000576	0.000682	CcSEcCtD
Metronidazole—Diarrhoea—Methotrexate—muscle cancer	0.000576	0.000681	CcSEcCtD
Metronidazole—Dizziness—Methotrexate—muscle cancer	0.000556	0.000659	CcSEcCtD
Metronidazole—Hypersensitivity—Doxorubicin—muscle cancer	0.000537	0.000635	CcSEcCtD
Metronidazole—Vomiting—Methotrexate—muscle cancer	0.000535	0.000633	CcSEcCtD
Metronidazole—Rash—Methotrexate—muscle cancer	0.00053	0.000628	CcSEcCtD
Metronidazole—Dermatitis—Methotrexate—muscle cancer	0.00053	0.000627	CcSEcCtD
Metronidazole—Headache—Methotrexate—muscle cancer	0.000527	0.000624	CcSEcCtD
Metronidazole—Asthenia—Doxorubicin—muscle cancer	0.000523	0.000619	CcSEcCtD
Metronidazole—Pruritus—Doxorubicin—muscle cancer	0.000515	0.00061	CcSEcCtD
Metronidazole—Nausea—Methotrexate—muscle cancer	0.0005	0.000592	CcSEcCtD
Metronidazole—Diarrhoea—Doxorubicin—muscle cancer	0.000498	0.00059	CcSEcCtD
Metronidazole—Dizziness—Doxorubicin—muscle cancer	0.000482	0.00057	CcSEcCtD
Metronidazole—Vomiting—Doxorubicin—muscle cancer	0.000463	0.000548	CcSEcCtD
Metronidazole—Rash—Doxorubicin—muscle cancer	0.000459	0.000544	CcSEcCtD
Metronidazole—Dermatitis—Doxorubicin—muscle cancer	0.000459	0.000543	CcSEcCtD
Metronidazole—Headache—Doxorubicin—muscle cancer	0.000456	0.00054	CcSEcCtD
Metronidazole—Nausea—Doxorubicin—muscle cancer	0.000433	0.000512	CcSEcCtD
